Current Report No: 13/2025
Date: June 17, 2025
Legal Basis: Article 56 (1) (2) of the act on Public Offering – Current and Periodic Information
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (the “Company“) hereby informs that on June 17, 2025, the Company received from the shareholder – Biofund Capital Management LLC (“BioFund“) a submission of draft resolution concerning the matter included in the agenda of the Ordinary General Meeting of the Company, which was convened for June 17, 2025, at 2:00 p.m., i.e. the notification:
- to item 14 of the agenda, which provides for the adoption of resolutions on the appointment of members of the Supervisory Board for the next term of office, together with the nomination of Mr. Maksymilian Fraszka for Member of the Supervisory Board of the Company in the election of members of the Supervisory Board at the Ordinary General Meeting of the Company convened for June 17, 2025.
In accordance with the justification for the shareholder’s request, the agenda of the Ordinary General Meeting included an item concerning the adoption of resolutions on the appointment of members of the Supervisory Board for the next term of office. The proposed draft resolution is in line with the agenda introduced by the Management Board.
The shareholder’s request was accompanied by draft resolution, resume (BIO) of candidate, and the consent of Mr. Maksymilian Fraszka to run for and be appointed to the Company’s Supervisory Board.
The draft resolution submitted by the shareholder on the matter included in the agenda and the resume (BIO) of the candidate are attached to the report.
Detailed Legal Basis: § 19(1)(4) of the Regulation of the Minister of Finance of March 29, 2018, on current and periodic information provided by issuers of securities and the conditions for recognizing information required by the laws of a non-member state as equivalent.